{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:37:27Z","timestamp":1790422647310,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institutes of Health\/National Institute of Arthritis and Musculoskeletal and Skin Diseases","award":["R03 AR065755"],"award-info":[{"award-number":["R03 AR065755"]}]},{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.imlet.2017.10.002","type":"journal-article","created":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T15:32:01Z","timestamp":1507735921000},"page":"55-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Current perspectives on the role of CD8+ T cells in systemic sclerosis"],"prefix":"10.1016","volume":"195","author":[{"given":"Patrizia","family":"Fuschiotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2017.10.002_bib0005","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"Gabrielli","year":"2009","journal-title":"Scleroderma The New England Journal of Medicine"},{"key":"10.1016\/j.imlet.2017.10.002_bib0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0889-857X(03)00023-1","article-title":"Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being","volume":"29","author":"Medsger","year":"2003","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.imlet.2017.10.002_bib0015","series-title":"Systemic Sclerosis","first-page":"17","article-title":"Classification, prognosis","author":"Medsger","year":"2004"},{"key":"10.1016\/j.imlet.2017.10.002_bib0020","first-page":"S42","article-title":"Assessment of disease severity and prognosis","volume":"21","author":"Medsger","year":"2003","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0025","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2017.10.002_bib0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1346-8138.2009.00738.x","article-title":"Mechanisms of skin fibrosis in systemic sclerosis","volume":"37","author":"Jinnin","year":"2010","journal-title":"J. Dermatol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0035","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/path.1711660307","article-title":"Sequential dermal microvascular and perivascular changes in the development of scleroderma","volume":"166","author":"Prescott","year":"1992","journal-title":"J. Pathol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0040","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/art.1780200410","article-title":"Cellular infiltrates in scleroderma skin","volume":"20","author":"Fleischmajer","year":"1977","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.10.002_bib0045","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/art.1780270607","article-title":"Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations","volume":"27","author":"Roumm","year":"1984","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.10.002_bib0050","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/BOR.0b013e32830c45ae","article-title":"T cells, B cells, and polarized immune response in the pathogenesis of fibrosis and systemic sclerosis","volume":"20","author":"Chizzolini","year":"2008","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0055","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0060","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/jid.2011.472","article-title":"Intrinsic gene expression subsets of diffuse cutaneous systemic sclerosis are stable in serial skin biopsies","volume":"132","author":"Pendergrass","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0065","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1046\/j.1365-2249.2002.02017.x","article-title":"Abnormal expression of intracellular cytokines and chemokine receptors in peripheral blood T lymphocytes from patients with systemic sclerosis","volume":"130","author":"Fujii","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0070","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/art.37860","article-title":"Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement","volume":"65","author":"Truchetet","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.10.002_bib0075","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/ar3486","article-title":"Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease","volume":"13","author":"Truchetet","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2017.10.002_bib0080","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1186\/ar4334","article-title":"Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts","volume":"15","author":"Brembilla","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2017.10.002_bib0085","doi-asserted-by":"crossref","first-page":"e5903","DOI":"10.1371\/journal.pone.0005903","article-title":"The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes","volume":"4","author":"Radstake","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2017.10.002_bib0090","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.autrev.2010.08.003","article-title":"Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis","volume":"10","author":"Baraut","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2017.10.002_bib0095","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.clim.2011.01.013","article-title":"Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis","volume":"139","author":"Fenoglio","year":"2011","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0100","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/rheumatology\/kes090","article-title":"T cells in systemic sclerosis: a reappraisal","volume":"51","author":"O'Reilly","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.imlet.2017.10.002_bib0105","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ajpath.2011.11.024","article-title":"Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targets","volume":"180","author":"Greenblatt","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0110","doi-asserted-by":"crossref","first-page":"e2696","DOI":"10.1371\/journal.pone.0002696","article-title":"Molecular subsets in the gene expression signatures of scleroderma skin","volume":"3","author":"Milano","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2017.10.002_bib0115","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1172\/JCI77958","article-title":"Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients","volume":"125","author":"Rice","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2017.10.002_bib0120","article-title":"Local skin gene expression reflects both local and systemic skin disease in patients with systemic sclerosis","author":"Rice","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.imlet.2017.10.002_bib0125","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/rheumatology\/31.7.457","article-title":"Reliability of skin involvement measures in scleroderma: the UK scleroderma study group","volume":"31","author":"Brennan","year":"1992","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0130","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/art.37706","article-title":"Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis","volume":"65","author":"Fuschiotti","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.10.002_bib0135","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-4632.2008.03615.x","article-title":"Immunohistochemical characterization of the cellular infiltrate in localized scleroderma","volume":"47","author":"Xie","year":"2008","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0140","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jid.2016.11.037","article-title":"Skin-resident effector memory CD8+CD28-T cells exhibit a profibrotic phenotype in patients with systemic sclerosis","volume":"137","author":"Li","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0145","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0198-8859(96)00091-2","article-title":"Skewing of the CD8+ T-cell repertoire in the lungs of patients with systemic sclerosis","volume":"48","author":"Yurovsky","year":"1996","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0150","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/art.24435","article-title":"Regulation of pulmonary inflammation and fibrosis through expression of integrins alphaVbeta3 and alphaVbeta5 on pulmonary T lymphocytes","volume":"60","author":"Luzina","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.10.002_bib0155","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/art.11080","article-title":"Occurrence of an activated, profibrotic pattern of gene expression in lung CD8+ T cells from scleroderma patients","volume":"48","author":"Luzina","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.10.002_bib0160","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/ard.49.1.40","article-title":"Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis","volume":"49","author":"Gustafsson","year":"1990","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.10.002_bib0165","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2362.1999.00434.x","article-title":"T-cell receptor gene usage in patients with fibrosing alveolitis and control subjects","volume":"29","author":"Lympany","year":"1999","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.imlet.2017.10.002_bib0170","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2249.2004.02647.x","article-title":"T cell repertoire in patients with stable scleroderma","volume":"139","author":"Tiev","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0175","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/art.20315","article-title":"Is systemic sclerosis an antigen-driven T cell disease","volume":"50","author":"Sakkas","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.10.002_bib0180","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1196\/annals.1358.016","article-title":"Evaluation of topoisomerase-1-specific CD8+ T-cell response in systemic sclerosis","volume":"1062","author":"Boin","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.imlet.2017.10.002_bib0185","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.4049\/jimmunol.177.7.4330","article-title":"Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules","volume":"177","author":"Takata","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0190","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/art.24432","article-title":"Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis","volume":"60","author":"Fuschiotti","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.10.002_bib0195","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1080\/08916934.2016.1217997","article-title":"Contribution of CD8+ T cells to inflammatory cytokine production in systemic sclerosis (SSc)","volume":"49","author":"Klein","year":"2016","journal-title":"Autoimmunity"},{"key":"10.1016\/j.imlet.2017.10.002_bib0200","doi-asserted-by":"crossref","first-page":"892","DOI":"10.4049\/jimmunol.1403046","article-title":"Increased CD226 expression on CD8+ T cells is associated with upregulated cytokine production and endothelial cell injury in patients with systemic sclerosis","volume":"195","author":"Ayano","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0205","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2017.10.002_bib0210","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0215","doi-asserted-by":"crossref","first-page":"279ra239","DOI":"10.1126\/scitranslmed.3010302","article-title":"Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells","volume":"7","author":"Watanabe","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.imlet.2017.10.002_bib0220","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/sj.jid.5700199","article-title":"A novel method for the isolation of skin resident T cells from normal and diseased human skin","volume":"126","author":"Clark","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0225","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.it.2015.05.003","article-title":"Emerging concepts in tissue-resident T cells: lessons from humans","volume":"36","author":"Thome","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0230","doi-asserted-by":"crossref","first-page":"269rv261","DOI":"10.1126\/scitranslmed.3010641","article-title":"Resident memory T cells in human health and disease","volume":"7","author":"Clark","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.imlet.2017.10.002_bib0235","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2567.2011.03470.x","article-title":"CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease","volume":"134","author":"Strioga","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.imlet.2017.10.002_bib0240","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.it.2009.03.013","article-title":"CD28(-) T cells: their role in the age-associated decline of immune function","volume":"30","author":"Weng","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0245","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/clim.2002.5271","article-title":"Divergent telomerase and CD28 expression patterns in human CD4 and CD8T cells following repeated encounters with the same antigenic stimulus","volume":"105","author":"Valenzuela","year":"2002","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0250","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fimmu.2017.00018","article-title":"Phenotypic alterations involved in CD8+ treg impairment in systemic sclerosis","volume":"8","author":"Negrini","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0255","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2567.2010.03334.x","article-title":"Human cytomegalovirus-specific CD8(+) T-cell expansions contain long-lived cells that retain functional capacity in both young and elderly subjects","volume":"132","author":"Wallace","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.imlet.2017.10.002_bib0260","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/80533","article-title":"Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells","volume":"6","author":"Lunardi","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.imlet.2017.10.002_bib0265","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/1529-0131(199902)42:2<389::AID-ANR23>3.0.CO;2-P","article-title":"Increased serum levels of antibodies against human cytomegalovirus and prevalence of autoantibodies in systemic sclerosis","volume":"42","author":"Neidhart","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.10.002_bib0270","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1086\/340637","article-title":"Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals","volume":"185","author":"Kern","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.imlet.2017.10.002_bib0275","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/art.38015","article-title":"Premature cell senescence and T cell receptor-independent activation of CD8+ T cells in juvenile idiopathic arthritis","volume":"65","author":"Dvergsten","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.10.002_bib0280","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/intimm\/11.2.229","article-title":"Differentiation of human CD8T cells: implications for in vivo persistence of CD8+ CD28- cytotoxic effector clones","volume":"11","author":"Posnett","year":"1999","journal-title":"Int. Immunol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0285","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0531-5565(99)00033-9","article-title":"Resistance to apoptosis in human CD8+ T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation","volume":"34","author":"Spaulding","year":"1999","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0290","doi-asserted-by":"crossref","first-page":"7710","DOI":"10.4049\/jimmunol.178.12.7710","article-title":"The loss of telomerase activity in highly differentiated CD8+CD28-CD27-T cells is associated with decreased Akt (Ser473) phosphorylation","volume":"178","author":"Plunkett","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0295","doi-asserted-by":"crossref","first-page":"7802","DOI":"10.4049\/jimmunol.177.11.7802","article-title":"Generation and growth of CD28nullCD8+ memory T cells mediated by IL-15 and its induced cytokines","volume":"177","author":"Chiu","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0300","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1002\/eji.200838250","article-title":"The capacity of the TNF family members 4-1BBL, OX40L, CD70, GITRL, CD30L and LIGHT to costimulate human T cells","volume":"38","author":"Kober","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0305","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1186\/ar2284","article-title":"Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease","volume":"9","author":"Wuttge","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2017.10.002_bib0310","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.autrev.2005.09.008","article-title":"Aging of the immune system: a risk factor for autoimmunity","volume":"5","author":"Prelog","year":"2006","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2017.10.002_bib0315","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/rheumatology\/35.8.732","article-title":"Telomere reduction in scleroderma patients: a possible cause for chromosomal instability","volume":"35","author":"Artlett","year":"1996","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0320","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.coi.2012.05.001","article-title":"Telomeres and immune competency","volume":"24","author":"Weng","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0325","doi-asserted-by":"crossref","first-page":"25066","DOI":"10.1038\/srep25066","article-title":"IL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics","volume":"6","author":"O'Reilly","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.imlet.2017.10.002_bib0330","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0335","first-page":"123","article-title":"Interferon-gamma and systemic autoimmunity","volume":"16","author":"Pollard","year":"2013","journal-title":"Discov. Med."},{"key":"10.1016\/j.imlet.2017.10.002_bib0340","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.immuni.2009.09.002","article-title":"Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases","volume":"31","author":"Hu","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2017.10.002_bib0345","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4049\/jimmunol.161.1.494","article-title":"IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice","volume":"161","author":"Schwarting","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0350","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0140-6736(09)60551-1","article-title":"Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial","volume":"374","author":"King","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2017.10.002_bib0355","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1002\/art.39287","article-title":"A longitudinal biomarker for the extent of skin disease in patients with diffuse cutaneous systemic sclerosis","volume":"67","author":"Rice","year":"2015","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.10.002_bib0360","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/art.38288","article-title":"Association of Interferon- and transforming growth factor beta-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis","volume":"66","author":"Christmann","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.10.002_bib0365","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s12026-011-8222-1","article-title":"CD8(+) T cells in systemic sclerosis","volume":"50","author":"Fuschiotti","year":"2011","journal-title":"Immunol. Res."},{"key":"10.1016\/j.imlet.2017.10.002_bib0370","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/1529-0131(199906)42:6<1168::AID-ANR13>3.0.CO;2-L","article-title":"Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis","volume":"42","author":"Atamas","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.10.002_bib0375","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/icb.2015.23","article-title":"Chemokines, their receptors and human disease: the good, the bad and the itchy","volume":"93","author":"Bryant","year":"2015","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0380","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1684\/ejd.2011.1469","article-title":"Up-regulation of CC chemokine ligand 20 and its receptor CCR6 in the lesional skin of early systemic sclerosis","volume":"21","author":"Tao","year":"2011","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0385","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/rheumatology\/ken401","article-title":"Monocyte chemoattractant proteins in the pathogenesis of systemic sclerosis","volume":"48","author":"Distler","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.imlet.2017.10.002_bib0390","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/rheumatology\/keh625","article-title":"Increased cutaneous T-cell-attracting chemokine levels in sera from patients with systemic sclerosis","volume":"44","author":"Hayakawa","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.imlet.2017.10.002_bib0395","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","article-title":"Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation","volume":"281","author":"Betts","year":"2003","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.imlet.2017.10.002_bib0400","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1084\/jem.190.6.815","article-title":"Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity","volume":"190","author":"Casciola-Rosen","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2017.10.002_bib0405","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1006\/clin.1996.4322","article-title":"Mechanism of serum-mediated endothelial injury in scleroderma: identification of a granular enzyme in scleroderma skin and sera","volume":"83","author":"Kahaleh","year":"1997","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.imlet.2017.10.002_bib0410","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1183\/09031936.00176807","article-title":"Apoptosis in lung injury and fibrosis","volume":"32","author":"Drakopanagiotakis","year":"2008","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.imlet.2017.10.002_bib0415","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1096\/fj.12-214189","article-title":"Apoptosis and angiogenesis: an evolving mechanism for fibrosis","volume":"27","author":"Johnson","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.imlet.2017.10.002_bib0420","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nm1081","article-title":"Effector CD8+ T cells mediate inflammation and airway hyper-responsiveness","volume":"10","author":"Miyahara","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.imlet.2017.10.002_bib0425","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1378\/chest.07-2626","article-title":"Tc2 response at the onset of COPD exacerbations","volume":"134","author":"Makris","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.imlet.2017.10.002_bib0430","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pharmthera.2008.09.001","article-title":"CD8+ T cells in asthma: friend or foe","volume":"121","author":"Betts","year":"2009","journal-title":"Pharmacol. Ther."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817303310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817303310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T23:58:53Z","timestamp":1693094333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247817303310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":86,"alternative-id":["S0165247817303310"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2017.10.002","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current perspectives on the role of CD8+ T cells in systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2017.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}